| Characteristics |
Number |
Percentage (%) |
| Age (in years) |
|
|
| <5 years |
85 |
40.47 |
| 5 - 10 years |
86 |
40.95 |
| >10 years |
39 |
18.57 |
| Sex |
|
|
| Female |
93 |
44.3 |
| Male |
117 |
55.7 |
| OMS clinical Stage |
|
|
| Stage 1 |
8 |
3.8 |
| Stage 2 |
65 |
31 |
| Stage 3 |
103 |
49 |
| Stage 4 |
34 |
16 |
| Immunological status |
128 |
|
| *L TCD4 < 15% |
94 |
73.43 |
| LTCD4 15% - 25% |
24 |
18.75 |
| LTCD4 > 25% |
10 |
7.8 |
| Statural growth |
|
|
| Normal |
120 |
57.14 |
| Moderate delay |
55 |
26.3 |
| Severe delay |
35 |
16.66 |
| Ponderal growth |
|
|
| Normal |
130 |
61.9 |
| Moderate delay |
55 |
26.19 |
| Severe delay |
25 |
11.9 |